Liquid biopsy panel for the detection of variants in non-small cell lung cancer from cfDNA

The UltraSEEK Lung Panel enables study of disease progression and resistance in non-small cell lung cancer.

• Detect over 70 clinically relevant variants across BRAF, EGFR, ERBB2, KRAS and PIK3CA
• Identify variants at as low as 0.1% variant allele frequency
• Use as little as 10 ng of cfDNA
• 1 hour of hands-on time and 8 hours of total time

Panel Resources